LGALS3 and acute kidney injury: We have recently identified Galectin-3 (Gal-3) as a key player in the progression of systemic pathways after renal ischemia-reperfusion in the context of type 3 cardiorenal syndrome (AKI leading to acute heart failure)6,7.